Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.40    2.10 (2.46%)
Bid:
87.00
Ask:
88.90
Spread: 1.90 (2.184%)
Market Cap: £367.39m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Interim Management Statement

19 Sep 2011 07:00

RNS Number : 4315O
PZ CUSSONS PLC
19 September 2011
 



19 September 2011

 

PZ Cussons Plc

(the "Group")

 

Interim Management Statement

 

PZ Cussons Plc today issues the following interim management statement which covers the period 1 June 2011 to 18 September 2011, in advance of its Annual General Meeting, to be held at 10:30am today.

 

Overview of financial position and performance

 

The Board is pleased to announce that the performance of the Group during the period has been in line with management expectations. The financial position of the Group remains strong with cash generation during the period also in line with expectations.

 

Trading Update

 

Europe

 

In the UK, trading in the core washing and bathing division has been robust although margins continue to be impacted by high promotional and raw material costs. New products to be launched at higher margins over the coming months include a new Carex range featuring advanced technology that continues to kill bacteria up to two hours after use.

 

The beauty division is trading well across the three brands of Sanctuary, St Tropez and Charles Worthington with good growth in the US offsetting tougher trading conditions in some UK distribution channels. New products to be launched include a Charles Worthington 'Salon at Home' range which will go into distribution in the UK and US over the coming months.

 

Performance in Poland and Greece has also been in line with expectations.

 

Asia

 

The positive momentum experienced in Indonesia in the second half of last year has continued with further growth in revenue and profitability.

 

Performance in Indonesia is helping to offset poorer trading conditions in Australia which have continued to worsen in our core categories with profitability further impacted by higher raw material costs.

 

Africa

 

The positive growth momentum has also continued in Nigeria across all business units of Home and Personal Care (HPC), Electricals and Food and Nutrition, although margins in HPC in particular have been impacted by the full effect of the continued rise in raw material costs.

 

Construction of the palm oil refinery with Wilmar in Nigeria is on schedule with completion due by the end of the 2012 calendar year.

 

Financial Position

 

The financial position of the Group is strong with a continuing net funds position. Normal capital expenditure is at the level of depreciation with the only additional project being the £17m investment in the joint venture with Wilmar in Nigeria.

 

Summary

 

The overall performance and position of the Group at the end of the period is in line with management expectations.

 

Trading momentum in most markets is positive giving cause for optimism. Margins continue to be affected by raw material cost increases with initiatives underway to recover these through higher selling prices and margin improvement projects.

 

A further update on the Group's performance will be given in the interim financial statements for the six months to 30 November 2011, to be announced at the end of January 2012.

 

 

- Ends -

 

For further information contact:

 

PZ Cussons Plc Tel: 0161 435 1016

Brandon Leigh

 

MHP Tel: 020 3128 8100

John Olsen /James White

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDKADPPBKDQCD
Date   Source Headline
31st Jul 20077:01 amRNSFinal Results
7th Jun 20077:01 amRNSTrading Statement
17th May 20077:01 amRNSNotice of trading update
19th Apr 200710:41 amRNSHolding(s) in Company
2nd Apr 20079:58 amRNSDirector/PDMR Shareholding
20th Mar 200711:57 amRNSHolding(s) in Company
13th Mar 20077:01 amRNSGPB26m investment
14th Feb 20079:59 amRNSHolding(s) in Company
30th Jan 20077:01 amRNSInterim Results
19th Dec 200611:40 amRNSDirectorate Change
19th Dec 200611:37 amRNSTotal Voting Rights
30th Nov 20067:01 amRNSTrading Statement
26th Sep 20067:02 amRNSResult of AGM
25th Sep 200612:00 pmRNSAGM Statement
19th Sep 20061:30 pmRNSDirector/PDMR Shareholding
4th Sep 20064:14 pmRNSGrant of Options
1st Aug 20067:00 amRNSFinal Results
1st Jun 20069:00 amRNSDirectorate Change
1st Jun 20067:01 amRNSPre-Close Update
6th Apr 20064:34 pmRNSDirectors interest in Shares
5th Apr 20061:09 pmRNSDirectors Interest in Shares
22nd Mar 200612:25 pmRNSDirectors Interest in Shares
3rd Mar 200611:30 amRNSDirectors Interest in Shares
1st Mar 20067:01 amRNSDirectorate Change
9th Feb 20068:48 amRNSDirector/PDMR Shareholding
7th Feb 20067:01 amRNSInterim Results
24th Jan 20067:00 amRNSNotice of Results
3rd Jan 20067:30 amRNSDirector Declaration
4th Oct 20059:00 amRNSDirectorate Change
3rd Oct 200510:20 amRNSDirectorate Change
26th Sep 200512:00 pmRNSAGM Statement
19th Sep 20053:21 pmRNSDirectors Interest in Shares
9th Sep 200510:36 amRNSDirectors Interest in Shares
8th Sep 200512:40 pmRNSDirectors Interest in Shares
24th Aug 20052:34 pmRNSDirectors Interest in Shares
15th Aug 20054:10 pmRNSDirectors Interest in Shares
2nd Aug 20057:01 amRNSFinal Results
28th Jul 20053:31 pmRNSNotice of Results
22nd Jul 200511:00 amRNSDirectorate Change
28th Jun 200512:35 pmRNSResult of Meetings
7th Jun 200512:00 pmRNSDirectorate Change
3rd Jun 20051:20 pmRNSNotice of EGM
2nd Jun 20057:01 amRNSProposed enfranchisement
1st Jun 20059:00 amRNSDirector Declaration
5th May 200512:00 pmRNSDirectorate Change
9th Mar 20054:43 pmRNSSecond Price Monitoring Extn
9th Mar 20054:38 pmRNSPrice Monitoring Extension
8th Feb 20057:00 amRNSInterim Results
10th Jan 20051:09 pmRNSNotice of Results
4th Jan 200510:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.